VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Latest News
@ArquerDx
What better time to refresh your knowledge of the signs and symptoms of #bladdercancer than during Bladder Cancer… https://t.co/Dxae8UA0Xy
@ArquerDx
As a #cancer sufferer, there is a lot of pressure to remain positive throughout diagnosis and treatment, but don't… https://t.co/RoviH5qjvI
@ArquerDx
Are you following our friends at @BladderCancerUK on Twitter? This is the best way to keep up to date with their cu… https://t.co/m29joemNFh